title: [Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far].
authors.affiliation: Kliniken för endokrinologi, metabolism och diabetes, Karolinska universitetssjukhuset, Stockholm. mikael.ryden@ki.se
authors.forename: Mikael
authors.initials: M
authors.lastname: Rydén
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin